News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
208,281 Results
Type
Article (9901)
Company Profile (54)
Press Release (198326)
Section
Business (70452)
Career Advice (265)
Deals (12346)
Drug Delivery (13)
Drug Development (27927)
Employer Resources (22)
FDA (5787)
Job Trends (5560)
News (116280)
Policy (10811)
Tag
Academia (1116)
Academic (1)
Accelerated approval (1)
Adcomms (1)
Allergies (47)
Alliances (11797)
ALS (30)
Alzheimer's disease (492)
Antibody-drug conjugate (ADC) (36)
Approvals (5859)
Artificial intelligence (51)
Autoimmune disease (4)
Automation (4)
Bankruptcy (82)
Best Places to Work (4971)
BIOSECURE Act (1)
Biosimilars (23)
Biotechnology (33)
Bladder cancer (32)
Brain cancer (12)
Breast cancer (122)
Cancer (804)
Cardiovascular disease (59)
Career advice (236)
Career pathing (4)
CAR-T (33)
Cell therapy (105)
Cervical cancer (11)
Clinical research (23849)
Collaboration (186)
Company closure (1)
Compensation (67)
Complete response letters (7)
COVID-19 (843)
CRISPR (7)
C-suite (41)
Cystic fibrosis (34)
Data (985)
Depression (10)
Diabetes (96)
Diagnostics (3046)
Digital health (5)
Diversity (1)
Diversity, equity & inclusion (6)
Drug discovery (31)
Drug pricing (12)
Drug shortages (2)
Duchenne muscular dystrophy (36)
Earnings (44908)
Editorial (5)
Employer branding (7)
Employer resources (18)
Events (29465)
Executive appointments (101)
FDA (6356)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (162)
Gene editing (24)
Generative AI (8)
Gene therapy (89)
GLP-1 (240)
Government (1622)
Grass and pollen (3)
Guidances (129)
Healthcare (8475)
Huntington's disease (4)
IgA nephropathy (10)
Immunology and inflammation (32)
Indications (16)
Infectious disease (903)
Inflammatory bowel disease (39)
Inflation Reduction Act (1)
Influenza (15)
Intellectual property (26)
Interviews (41)
IPO (7458)
IRA (3)
Job creations (814)
Job search strategy (200)
Kidney cancer (3)
Labor market (14)
Layoffs (186)
Leadership (3)
Legal (2466)
Liver cancer (16)
Lung cancer (143)
Lymphoma (67)
Machine learning (1)
Management (6)
Manufacturing (67)
MASH (39)
Medical device (6789)
Medtech (6789)
Mergers & acquisitions (5078)
Metabolic disorders (231)
Multiple sclerosis (42)
NASH (9)
Neurodegenerative disease (22)
Neuropsychiatric disorders (2)
Neuroscience (676)
NextGen: Class of 2025 (2609)
Non-profit (1928)
Now hiring (5)
Obesity (98)
Opinion (52)
Ovarian cancer (26)
Pain (31)
Pancreatic cancer (26)
Parkinson's disease (53)
Partnered (8)
Patents (49)
Patient recruitment (23)
Peanut (26)
People (11659)
Pharmaceutical (17)
Pharmacy benefit managers (4)
Phase I (6407)
Phase II (10074)
Phase III (9257)
Pipeline (822)
Policy (16)
Postmarket research (1040)
Preclinical (2061)
Press Release (12)
Prostate cancer (39)
Psychedelics (4)
Radiopharmaceuticals (73)
Rare diseases (127)
Real estate (1546)
Recruiting (7)
Regulatory (7445)
Reports (19)
Research institute (949)
Resumes & cover letters (31)
Rett syndrome (5)
RNA editing (1)
RSV (24)
Schizophrenia (33)
Series A (24)
Series B (13)
Service/supplier (4)
Sickle cell disease (17)
Special edition (8)
Spinal muscular atrophy (60)
Sponsored (8)
Startups (787)
Stomach cancer (3)
Supply chain (14)
Tariffs (9)
The Weekly (2)
Vaccines (264)
Venture capitalists (5)
Weight loss (60)
Women's health (4)
Worklife (2)
Date
Today (79)
Last 7 days (407)
Last 30 days (1004)
Last 365 days (10964)
2025 (3863)
2024 (11810)
2023 (13217)
2022 (14853)
2021 (16747)
2020 (15781)
2019 (13222)
2018 (29102)
2017 (14296)
2016 (7748)
2015 (9587)
2014 (6734)
2013 (4998)
2012 (5269)
2011 (5827)
2010 (5165)
Location
Africa (188)
Alabama (10)
Alaska (1)
Arizona (62)
Arkansas (3)
Asia (12762)
Australia (1603)
California (1987)
Canada (742)
China (204)
Colorado (83)
Connecticut (90)
Delaware (71)
Europe (27719)
Florida (292)
Georgia (94)
Idaho (20)
Illinois (165)
India (10)
Indiana (140)
Iowa (2)
Japan (54)
Kansas (48)
Kentucky (5)
Louisiana (7)
Maine (26)
Maryland (279)
Massachusetts (1391)
Michigan (51)
Minnesota (128)
Missouri (17)
Montana (6)
Nebraska (4)
Nevada (21)
New Hampshire (17)
New Jersey (769)
New Mexico (3)
New York (635)
North Carolina (306)
North Dakota (1)
Northern California (944)
Ohio (45)
Oregon (8)
Pennsylvania (539)
Puerto Rico (2)
Rhode Island (11)
South America (288)
South Carolina (6)
South Dakota (1)
Southern California (743)
Tennessee (20)
Texas (290)
United States (7744)
Utah (70)
Virginia (30)
Washington D.C. (26)
Washington State (170)
Wisconsin (10)
208,281 Results for "18".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FDA Roundup: March 18, 2025
March 19, 2025
·
3 min read
Press Releases
Positive Outcome in 75% of CTCL Patients Treated with HyBryte™ for 18 Weeks
April 15, 2025
·
18 min read
Artificial intelligence
Sanofi Bets More Than $1.8 Billion in Biobucks on AI-Developed Bispecifics
The French pharma giant has made multiple trips to the artificial intelligence well over the past few years, this time with Delaware-based Earendial Labs.
April 17, 2025
·
2 min read
·
Dan Samorodnitsky
Deals
Roche Inks Potential $1.8B Deal With Flare to Target Transcription Factors in Cancer
With $70 million upfront and more than $1.8 billion on the line, Roche will gain access to Flare’s drug discovery engine to bolster its oncology pipeline.
November 12, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Curium receives marketing authorization in Switzerland for PYLCLARI® – an innovative 18F-PSMA PET tracer indicated in patients with prostate cancer
May 12, 2025
·
3 min read
Press Releases
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 18, 2025
April 21, 2025
·
1 min read
Press Releases
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 18, 2025
April 21, 2025
·
2 min read
Press Releases
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - April 18, 2025
April 21, 2025
·
2 min read
Press Releases
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - April 18, 2025
April 21, 2025
·
7 min read
Press Releases
Redwire to Present at 37th Annual Roth Conference on March 18, 2025
March 17, 2025
·
10 min read
1 of 20,829
Next
